Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 22.24 ▼ -0.00 (-0.02%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Nektar Therapeutics (MM) | NKTR | NASDAQ | Common Stock | US6402681083 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.07 | +0.32% | 22.24 | 22.82 | 21.98 | 22.19 | 22.17 | 17:15:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 21.88 | 22.81 | 0.93 | 4.08% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,225 | 1,871,801 | $ 22.3071 | $ 41.75M | 1.17M | 11.41 - 24.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:33:45 | formt | 568 | $22.24 | USD |
Nektar Therapeutics (MM) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.45B | 155.15M | $ -153.52M | -1.10 | 0.00 | 88.71M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 11.14M | $ 0.00 | 0.00% | -30.47k | 91.40% |
Nektar Therapeutics (MM) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/21/2017 | 09:21 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 7/20/2017 | 17:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 7/18/2017 | 08:11 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 7/18/2017 | 08:00 | PR Newswire (US) | Nektar Announces Topline Data from Human Abuse Potential.. |
| 7/10/2017 | 09:00 | PR Newswire (US) | Nektar Presents New Preclinical Data for NKTR-358, a.. |
| 6/28/2017 | 18:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/15/2017 | 17:25 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NKTR Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 20.7 | 22.82 | 20.4 | 0.0000 | 460k | 2M | 1M | 1.54 | 7.44% |
| 1 Month | 19.5 | 22.82 | 18.78 | 0.0000 | 364k | 2M | 921k | 2.74 | 14.05% |
| 3 Months | 19 | 22.82 | 17.33 | 0.0000 | 364k | 3M | 1M | 3.24 | 17.05% |
| 6 Months | 12.19 | 24.88 | 11.41 | 0.0000 | 241k | 15M | 2M | 10.05 | 82.44% |
| 1 Year | 15.38 | 24.88 | 11.41 | 0.0000 | 241k | 15M | 1M | 6.86 | 44.60% |
| 3 Years | 10.93 | 24.88 | 9.16 | 0.0000 | 0 | 15M | 1M | 11.31 | 103.48% |
| 5 Years | 8.9 | 24.88 | 5.65 | 0.0000 | 0 | 15M | 1M | 13.34 | 149.89% |
Nektar Therapeutics (MM) Description
| Nektar Therapeutics, Inc, is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. |
